Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 2, 2008 - Issue 3
Submit an article Journal homepage
39
Views
18
CrossRef citations to date
0
Altmetric
Review

Statins as emerging treatments for asthma and chronic obstructive pulmonary disease

Garry M Walsh School of Medicine, IMS Building, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK. [email protected]
Pages 329-335 | Published online: 09 Jan 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alaa S. Tulbah, Hui Xin Ong, Paolo Colombo, Paul M. Young & Daniela Traini. (2016) Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons. Expert Opinion on Drug Delivery 13:10, pages 1407-1420.
Read now
Garry M Walsh. (2008) Emerging drugs for asthma. Expert Opinion on Emerging Drugs 13:4, pages 643-653.
Read now

Articles from other publishers (16)

Anton Nilsson, Kleoniki Tsoumani & Tereza Planck. (2021) Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease. The Journal of Clinical Endocrinology & Metabolism 106:5, pages 1325-1332.
Crossref
Yi-Hsuan Wei, Shu-Lang Liao, Chia-Chun Wang, Sen-Hsu Wang, Wan-Chun Tang & Chang-Hao Yang. (2021) Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves’ Ophthalmopathy through the Regulation of FoxO3a Signaling. Mediators of Inflammation 2021, pages 1-12.
Crossref
Alaa S. Tulbah. (2020) The potential of Atorvastatin for chronic lung diseases therapy. Saudi Pharmaceutical Journal 28:11, pages 1353-1363.
Crossref
Giulia Lanzolla, Guia Vannucchi, Ilaria Ionni, Irene Campi, Federica Sileo, Elisa Lazzaroni & Michele Marinò. (2020) Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy. Frontiers in Endocrinology 10.
Crossref
Peta Bradbury, Daniela Traini, Alaina J. Ammit, Paul M. Young & Hui Xin Ong. (2018) Repurposing of statins via inhalation to treat lung inflammatory conditions. Advanced Drug Delivery Reviews 133, pages 93-106.
Crossref
J. Ferreira, M. Drummond, N. Pires, G. Reis, C. Alves & C. Robalo-Cordeiro. (2016) Optimal treatment sequence in COPD: Can a consensus be found?. Revista Portuguesa de Pneumologia (English Edition) 22:1, pages 39-49.
Crossref
Rama K. Krishna, Omar Issa, Debjit Saha, Francisco Yuri B. Macedo, Barbara Correal & Orlando Santana. (2015) Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: A comprehensive review. Pulmonary Pharmacology & Therapeutics 30, pages 134-140.
Crossref
Alessandra Buja, Deris Gianni Boemo, Patrizia Furlan, Chiara Bertoncello, Patrizia Casale, Tatjana Baldovin, Adriano Marcolongo & Vincenzo Baldo. (2012) Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?. European Journal of Preventive Cardiology 21:2, pages 222-230.
Crossref
Garry M. Walsh. (2013) Eosinophil Apoptosis and Clearance in Asthma. Journal of Cell Death 6, pages JCD.S10818.
Crossref
Xia Sheng, Michael J Murphy, Thomas M MacDonald & Li Wei. (2012) The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population. BMC Public Health 12:1.
Crossref
MASASHI BANDO, TADASHI MIYAZAWA, HIDEKI SHINOHARA, TOSHIO OWADA, MICHIYUKI TERAKADO & YUKIHIKO SUGIYAMA. (2012) An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease. Respirology 17:3, pages 493-498.
Crossref
Xia Sheng, Michael J. Murphy, Thomas M. MacDonald, Stuart Schembri, William Simpson, Janet Winter, John H. Winter & Li Wei. (2012) Effect of Statins on Total Cholesterol Concentrations, Cardiovascular Morbidity, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study. Clinical Therapeutics 34:2, pages 374-384.
Crossref
Carlene MM Lawes, Simon Thornley, Robert Young, Raewyn Hopkins, Roger Marshall, Wing Cheuk Chan & Gary Jackson. (2012) Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. Primary Care Respiratory Journal 21:1, pages 35-40.
Crossref
Peter J BarnesEmiel Wouters. 2012. Addressing Unmet Medical Needs in COPD Management. Addressing Unmet Medical Needs in COPD Management 40 51 .
Surinder Janda, Kirly Park, J. Mark FitzGerald, Mahyar Etminan & John Swiston. (2009) Statins in COPD. Chest 136:3, pages 734-743.
Crossref
R P Young, R Hopkins & T E Eaton. (2009) Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgraduate Medical Journal 85:1006, pages 414-421.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.